[1] |
VASAIKAR S, HUANG C, WANG X J, et al. Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities[J]. Cell, 2019, 177(4): 1035-1049.e19.
doi: S0092-8674(19)30292-2
pmid: 31031003
|
[2] |
BOLAND C R, GOEL A. Microsatellite instability in colorectal cancer[J]. Gastroenterology, 2010, 138(6): 2073-2087.e3.
doi: 10.1053/j.gastro.2009.12.064
pmid: 20420947
|
[3] |
LYNCH H T, DE LA CHAPELLE A. Hereditary colorectal cancer[J]. N Engl J Med, 2003, 348(10): 919-932.
doi: 10.1056/NEJMra012242
|
[4] |
HERMAN J G, UMAR A, POLYAK K, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma[J]. Proc Natl Acad Sci USA, 1998, 95(12): 6870-6875.
doi: 10.1073/pnas.95.12.6870
|
[5] |
CHEN M L, CHEN J Y, HU J, et al. Comparison of microsatellite status detection methods in colorectal carcinoma[J]. Int J Clin Exp Pathol, 2018, 11(3): 1431-1438.
|
[6] |
DUDLEY J C, LIN M T, LE D T, et al. Microsatellite instability as a biomarker for PD-1 blockade[J]. Clin Cancer Res, 2016, 22(4): 813-820.
doi: 10.1158/1078-0432.CCR-15-1678
pmid: 26880610
|
[7] |
EVRARD C, TACHON G, RANDRIAN V, et al. Microsatellite instability: diagnosis, heterogeneity, discordance, and clinical impact in colorectal cancer[J]. Cancers (Basel), 2019, 11(10): E1567.
|
[8] |
COHEN R, HAIN E, BUHARD O, et al. Association of primary resistance to immune checkpoint inhibitors in metastatic colorectal cancer with misdiagnosis of microsatellite instability or mismatch repair deficiency status[J]. JAMA Oncol, 2019, 5(4): 551-555.
doi: 10.1001/jamaoncol.2018.4942
pmid: 30452494
|
[9] |
UMAR A, BOLAND C R, TERDIMAN J P, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability[J]. J Natl Cancer Inst, 2004, 96(4): 261-268.
doi: 10.1093/jnci/djh034
pmid: 14970275
|
[10] |
LINDEMAN N I, CAGLE P T, BEASLEY M B, et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology[J]. J Thorac Oncol, 2013, 8(7): 823-859.
doi: 10.1097/JTO.0b013e318290868f
pmid: 23552377
|
[11] |
SAMAISON L, GRALL M, STAROZ F, et al. Microsatellite instability diagnosis using the fully automated Idylla platform: feasibility study of an in-house rapid molecular testing ancillary to immunohistochemistry in pathology laboratories[J]. J Clin Pathol, 2019, 72(12): 830-835.
doi: 10.1136/jclinpath-2019-205935
pmid: 31235541
|
[12] |
LEE M, CHUN S M, SUNG C O, et al. Clinical utility of a fully automated microsatellite instability test with minimal hands-on time[J]. J Pathol Transl Med, 2019, 53(6): 386-392.
doi: 10.4132/jptm.2019.09.25
pmid: 31606978
|
[13] |
LI X, XU J, LI L, et al. Evaluation of a fully automated idylla test system for microsatellite instability in colorectal cancer[J]. Clin Colorectal Cancer, 2019, 18(4): e316-e323.
doi: 10.1016/j.clcc.2019.05.006
|
[14] |
ZWAENEPOEL K, HOLMGAARD DUELUND J, DE WINNE K, et al. Clinical performance of the idylla MSI test for a rapid assessment of the DNA microsatellite status in human colorectal cancer[J]. J Mol Diagn, 2020, 22(3): 386-395.
doi: S1525-1578(19)30458-1
pmid: 31881332
|
[15] |
LE D T, URAM J N, WANG H, et al. PD-1 blockade in tumors with mismatch-repair deficiency[J]. N Engl J Med, 2015, 372(26): 2509-2520.
doi: 10.1056/NEJMoa1500596
|
[16] |
LE D T, DURHAM J N, SMITH K N, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade[J]. Science, 2017, 357(6349): 409-413.
doi: 10.1126/science.aan6733
pmid: 28596308
|
[17] |
AGUIAR P N Jr, TADOKORO H, FORONES N M, et al. MMR deficiency may lead to a high immunogenicity and then an improvement in anti-PD-1 efficacy for metastatic colorectal cancer[J]. Immunotherapy, 2015, 7(11): 1133-1134.
doi: 10.2217/imt.15.84
pmid: 26568256
|
[18] |
ZHAO H, THIENPONT B, YESILYURT B T, et al. Mismatch repair deficiency endows tumors with a unique mutation signature and sensitivity to DNA double-strand breaks[J]. Elife, 2014, 3: e02725.
doi: 10.7554/eLife.02725
|
[19] |
UGUEN A, TRONCONE G. A review on the Idylla platform: towards the assessment of actionable genomic alterations in one day[J]. J Clin Pathol, 2018, 71(9): 757-762.
doi: 10.1136/jclinpath-2018-205189
pmid: 29903742
|
[20] |
PÉCRIAUX A, FAVRE L, CALDERARO J, et al. Detection of microsatellite instability in a panel of solid tumours with the Idylla MSI Test using extracted DNA[J]. J Clin Pathol, 2021, 74(1): 36-42.
doi: 10.1136/jclinpath-2020-206581
pmid: 32513848
|
[21] |
PENG J J, HUANG D, POSTON G, et al. The molecular heterogeneity of sporadic colorectal cancer with different tumor sites in Chinese patients[J]. Oncotarget, 2017, 8(30): 49076-49083.
doi: 10.18632/oncotarget.16176
pmid: 28416767
|
[22] |
VELASCO A, TOKAT F, BONDE J, et al. Multi-center real-world comparison of the fully automated IdyllaTM microsatellite instability assay with routine molecular methods and immunohistochemistry on formalin-fixed paraffin-embedded tissue of colorectal cancer[J]. Virchows Arch, 2021, 478(5): 851-863.
doi: 10.1007/s00428-020-02962-x
|
[23] |
HAUSE R J, PRITCHARD C C, SHENDURE J, et al. Classification and characterization of microsatellite instability across 18 cancer types[J]. Nat Med, 2016, 22(11): 1342-1350.
doi: 10.1038/nm.4191
pmid: 27694933
|